ARTICLE | Clinical News
Gamunex immune globulin intravenous regulatory update
September 1, 2003 7:00 AM UTC
The FDA approved for marketing BAYG's Gamunex for patients with compromised immune systems. Gamunex, which was approved in Canada in August, will be available in Canada early next year and in the U.S....